The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 10, 2026 | Altmeyer Anne | Director | Sell(S) | 2K | $7.91 | $19K |
| Jun 10, 2026 | Jenkins John Kenneth | Director | Sell(S) | 5K | $7.91 | $38K |
| Jun 10, 2026 | Kung Winston | Director | Sell(S) | 2K | $7.91 | $16K |
| Jun 3, 2026 | Saxena Nishant C | Chief Business Officer | Buy(P) | 9K | $7.58 | $68K |
| Jun 2, 2026 | Saxena Nishant C | Chief Business Officer | Buy(P) | 5K | $7.33 | $33K |
| May 21, 2026 | Saxena Nishant C | Chief Business Officer | Grant(A) | 58K | — | $0 |
| May 21, 2026 | Saxena Nishant C | Chief Business Officer | Grant(A) | 192K | — | $0 |
| May 19, 2026 | Altmeyer Anne | Director | Grant(A) | 4K | — | $0 |
| May 19, 2026 | Altmeyer Anne | Director | Grant(A) | 12K | — | $0 |
| May 19, 2026 | Ben Yong | Director | Grant(A) | 4K | — | $0 |
| May 19, 2026 | Ben Yong | Director | Grant(A) | 12K | — | $0 |
| May 19, 2026 | Pfeiffenberger Brent | Director | Grant(A) | 8K | — | $0 |
| May 19, 2026 | Pfeiffenberger Brent | Director | Grant(A) | 25K | — | $0 |
| May 19, 2026 | Jenkins John Kenneth | Director | Grant(A) | 4K | — | $0 |
| May 19, 2026 | Jenkins John Kenneth | Director | Grant(A) | 12K | — | $0 |
| May 19, 2026 | Jacques Rachelle Suzanne | Director | Grant(A) | 4K | — | $0 |
| May 19, 2026 | Jacques Rachelle Suzanne | Director | Grant(A) | 12K | — | $0 |
| May 19, 2026 | Kung Winston | Director | Grant(A) | 4K | — | $0 |
| May 19, 2026 | Kung Winston | Director | Grant(A) | 12K | — | $0 |
| Mar 2, 2026 | Smethurst Dominic | Chief Medical Officer | Sell(S) | 6K | $8.30 | $51K |
| Feb 17, 2026 | Hodgson Ian | Chief Operating Officer | Sell(S) | 847 | $7.38 | $6K |
| Feb 13, 2026 | Cohen Yuval | Chief Executive Officer, Director | Sell(S) | 14K | $7.78 | $108K |
| Feb 13, 2026 | Moran Sean F. | Chief Financial Officer | Sell(S) | 5K | $7.78 | $37K |
| Feb 3, 2026 | Hodgson Ian | Chief Operating Officer | Sell(S) | 2K | $8.09 | $20K |
| Feb 3, 2026 | Smethurst Dominic | Chief Medical Officer | Sell(S) | 3K | $8.09 | $27K |
| Jan 14, 2026 | Cohen Yuval | Chief Executive Officer, Director | Grant(A) | 50K | — | $0 |
| Jan 14, 2026 | Cohen Yuval | Chief Executive Officer, Director | Grant(A) | 150K | — | $0 |
| Jan 14, 2026 | Moran Sean F. | Chief Financial Officer | Grant(A) | 28K | — | $0 |
| Jan 14, 2026 | Moran Sean F. | Chief Financial Officer | Grant(A) | 84K | — | $0 |
| Jan 14, 2026 | Smethurst Dominic | Chief Medical Officer | Grant(A) | 28K | — | $0 |
| Jan 14, 2026 | Smethurst Dominic | Chief Medical Officer | Grant(A) | 85K | — | $0 |
| Jan 14, 2026 | Hodgson Ian | Chief Operating Officer | Grant(A) | 28K | — | $0 |
| Jan 14, 2026 | Hodgson Ian | Chief Operating Officer | Grant(A) | 85K | — | $0 |
| Dec 11, 2025 | Chen Bihua | 10% Owner | Sell(S) | 30K | $11.46 | $344K |
| Oct 27, 2025 | Cohen Yuval | Chief Executive Officer, Director | Sell(S) | 9K | $17.14 | $154K |
| Oct 27, 2025 | Cohen Yuval | Chief Executive Officer, Director | Option exercise(M) | 9K | $4.26 | $38K |
| Oct 27, 2025 | Cohen Yuval | Chief Executive Officer, Director | Option exercise(M) | 9K | — | $0 |
| Oct 24, 2025 | Moran Sean F. | Chief Financial Officer | Sell(S) | 13K | $17.02 | $221K |
| Oct 24, 2025 | Moran Sean F. | Chief Financial Officer | Option exercise(M) | 13K | $4.26 | $55K |
| Oct 24, 2025 | Moran Sean F. | Chief Financial Officer | Option exercise(M) | 13K | — | $0 |
| Oct 24, 2025 | Cohen Yuval | Chief Executive Officer, Director | Sell(S) | 19K | $17.01 | $317K |
| Oct 24, 2025 | Cohen Yuval | Chief Executive Officer, Director | Option exercise(M) | 19K | $4.26 | $79K |
| Oct 24, 2025 | Cohen Yuval | Chief Executive Officer, Director | Option exercise(M) | 19K | — | $0 |
| Oct 20, 2025 | Altmeyer Anne | Director | Option exercise(M) | 1K | $4.80 | $5K |
| Oct 20, 2025 | Altmeyer Anne | Director | Sell(S) | 1K | $20.50 | $22K |
| Oct 20, 2025 | Altmeyer Anne | Director | Option exercise(M) | 1K | — | $0 |
| May 30, 2025 | Jacques Rachelle Suzanne | Director | Grant(A) | 5K | — | $0 |
| May 30, 2025 | Jacques Rachelle Suzanne | Director | Grant(A) | 16K | — | $0 |
| May 30, 2025 | Holmer Alan F | Director | Grant(A) | 5K | — | $0 |
| May 30, 2025 | Holmer Alan F | Director | Grant(A) | 16K | — | $0 |
| May 30, 2025 | Altmeyer Anne | Director | Sell(S) | 1K | $7.25 | $10K |
| May 30, 2025 | Altmeyer Anne | Director | Grant(A) | 5K | — | $0 |
| May 30, 2025 | Altmeyer Anne | Director | Grant(A) | 16K | — | $0 |
| May 30, 2025 | Jenkins John Kenneth | Director | Grant(A) | 5K | — | $0 |
| May 30, 2025 | Jenkins John Kenneth | Director | Sell(S) | 3K | $7.35 | $20K |
| May 30, 2025 | Jenkins John Kenneth | Director | Grant(A) | 16K | — | $0 |
| May 30, 2025 | Ben Yong | Director | Grant(A) | 5K | — | $0 |
| May 30, 2025 | Ben Yong | Director | Grant(A) | 16K | — | $0 |
| May 30, 2025 | Kung Winston | Director | Grant(A) | 5K | — | $0 |
| May 30, 2025 | Kung Winston | Director | Grant(A) | 16K | — | $0 |
| Mar 6, 2025 | Smethurst Dominic | Chief Medical Officer | Sell(S) | 6K | $6.78 | $43K |
| Feb 14, 2025 | Cohen Yuval | Chief Executive Officer, Director | Sell(S) | 7K | $8.76 | $62K |
| Feb 14, 2025 | Moran Sean F. | Chief Financial Officer | Sell(S) | 3K | $8.76 | $24K |
| Jan 31, 2025 | Cohen Yuval | Chief Executive Officer, Director | Grant(A) | 68K | — | $0 |
| Jan 31, 2025 | Cohen Yuval | Chief Executive Officer, Director | Grant(A) | 229K | — | $0 |
| Jan 31, 2025 | Moran Sean F. | Chief Financial Officer | Grant(A) | 28K | — | $0 |
| Jan 31, 2025 | Moran Sean F. | Chief Financial Officer | Grant(A) | 93K | — | $0 |
| Jan 31, 2025 | Smethurst Dominic | Chief Medical Officer | Grant(A) | 27K | — | $0 |
| Jan 31, 2025 | Smethurst Dominic | Chief Medical Officer | Grant(A) | 91K | — | $0 |
| Sep 20, 2024 | Cormorant Global Healthcare Master Fund, LP | 10% Owner | Buy(P) | 26K | $18.36 | $476K |
| Sep 20, 2024 | Cormorant Global Healthcare Master Fund, LP | 10% Owner | Buy(P) | 45K | $17.48 | $788K |
| Sep 20, 2024 | Cormorant Global Healthcare Master Fund, LP | 10% Owner | Buy(P) | 26K | $22.23 | $573K |
| Sep 20, 2024 | Cormorant Global Healthcare Master Fund, LP | 10% Owner | Buy(P) | 140K | $20.42 | $2.8M |
| Sep 20, 2024 | Cormorant Global Healthcare Master Fund, LP | 10% Owner | Buy(P) | 66K | $19.61 | $1.3M |
| Sep 20, 2024 | Cormorant Global Healthcare Master Fund, LP | 10% Owner | Buy(P) | 48K | $21.47 | $1.0M |
| Aug 16, 2024 | Kung Winston | Director | Grant(A) | 6K | — | $0 |
| Aug 16, 2024 | Kung Winston | Director | Grant(A) | 6K | — | $0 |
| Jun 18, 2024 | Cohen Yuval | Chief Executive Officer, Director | Option exercise(M) | 12K | $30.00 | $350K |
| Jun 18, 2024 | Cohen Yuval | Chief Executive Officer, Director | Sell(S) | 12K | $42.24 | $493K |
| Jun 18, 2024 | Cohen Yuval | Chief Executive Officer, Director | Sell(S) | 2K | $42.24 | $98K |
| Jun 18, 2024 | Cohen Yuval | Chief Executive Officer, Director | Option exercise(M) | 2K | $4.26 | $10K |
| Jun 18, 2024 | Cohen Yuval | Chief Executive Officer, Director | Sell(S) | 2K | $42.24 | $75K |
| Jun 18, 2024 | Cohen Yuval | Chief Executive Officer, Director | Option exercise(M) | 2K | $14.10 | $25K |
| Jun 18, 2024 | Cohen Yuval | Chief Executive Officer, Director | Sell(S) | 7K | $42.24 | $303K |
| Jun 18, 2024 | Cohen Yuval | Chief Executive Officer, Director | Option exercise(M) | 2K | — | $0 |
| Jun 18, 2024 | Cohen Yuval | Chief Executive Officer, Director | Option exercise(M) | 12K | — | $0 |
| Jun 18, 2024 | Cohen Yuval | Chief Executive Officer, Director | Option exercise(M) | 2K | — | $0 |
| Jun 18, 2024 | Moran Sean F. | Chief Financial Officer | Option exercise(M) | 2K | $30.00 | $59K |
| Jun 18, 2024 | Moran Sean F. | Chief Financial Officer | Sell(S) | 2K | $42.12 | $82K |
| Jun 18, 2024 | Moran Sean F. | Chief Financial Officer | Option exercise(M) | 2K | — | $0 |
| Jun 17, 2024 | Cohen Yuval | Chief Executive Officer, Director | Option exercise(M) | 2K | $4.26 | $8K |
| Jun 17, 2024 | Cohen Yuval | Chief Executive Officer, Director | Sell(S) | 9K | $46.02 | $430K |
| Jun 17, 2024 | Cohen Yuval | Chief Executive Officer, Director | Sell(S) | 2K | $46.02 | $81K |
| Jun 17, 2024 | Cohen Yuval | Chief Executive Officer, Director | Option exercise(M) | 9K | $30.00 | $280K |
| Jun 17, 2024 | Cohen Yuval | Chief Executive Officer, Director | Option exercise(M) | 9K | — | $0 |
| Jun 17, 2024 | Cohen Yuval | Chief Executive Officer, Director | Option exercise(M) | 2K | — | $0 |
| Jun 17, 2024 | Moran Sean F. | Chief Financial Officer | Sell(S) | 7K | $46.77 | $315K |
| Jun 17, 2024 | Moran Sean F. | Chief Financial Officer | Option exercise(M) | 7K | $14.10 | $95K |
| Jun 17, 2024 | Moran Sean F. | Chief Financial Officer | Option exercise(M) | 7K | — | $0 |
| Jun 14, 2024 | Holmer Alan F | Director | Option exercise(M) | 2K | $30.00 | $50K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-01-04 → 2026-07-21. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).